Metabolic imaging in prostate cancer: where we are
In recent years, the development of diagnostic methods based on metabolic imaging has been aimed at improving diagnosis of prostate cancer (PCa) and perhaps at improving therapy. Molecular imaging methods can detect specific biological processes that are different when detected within cancer cells r...
Main Authors: | Claudia Testa, Cristian Pultrone, David Neil Manners, Riccardo Schiavina, Raffaele Lodi |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2016-11-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fonc.2016.00225/full |
Similar Items
-
Detecting localised prostate cancer using radiomic features in PSMA PET and multiparametric MRI for biologically targeted radiation therapy
by: Tsz Him Chan, et al.
Published: (2023-04-01) -
Gleason Grade Group 4 prostate biopsy with no cancer seen on final pathology in the magnetic resonance imaging and Prostate Specific Membrane Antigen‐Positron Emission Tomography era
by: Nikhile Mookerji, et al.
Published: (2023-11-01) -
Interactive, multi-modality image registrations for combined MRI/MRSI-planned HDR prostate brachytherapy
by: Galen Reed, et al.
Published: (2011-03-01) -
DEPROMP Trial: the additive value of PSMA-PET/CT-guided biopsy for prostate cancer management in biopsy naïve men—study protocol for a randomized trial
by: P. Krausewitz, et al.
Published: (2023-03-01) -
Granulomatous prostatitis with high suspicion of prostatic adenocarcinoma on radiological imaging
by: Yoshiki Ambe, et al.
Published: (2021-07-01)